Literature DB >> 12374024

ELISA.

Joyce S Plested1, Philip A Coull, Margaret Anne J Gidney.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12374024     DOI： 10.1385/1-59259-321-6:243

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  6 in total

1.  Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.

Authors:  Kazutoyo Miura; Andrew C Orcutt; Olga V Muratova; Louis H Miller; Allan Saul; Carole A Long
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

2.  Monoclonal Antibodies as Probes to Study Ligand-Induced Conformations of Troponin Subunits.

Authors:  Monica Rasmussen; Jian-Ping Jin
Journal:  Front Physiol       Date:  2022-03-25       Impact factor: 4.566

3.  CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited.

Authors:  Matthew A Helsby; Paul M Leader; Joe R Fenn; Tulay Gulsen; Chris Bryant; Gail Doughton; Ben Sharpe; Paul Whitley; Christopher J Caunt; Katrina James; Adam D Pope; Dave H Kelly; Andrew D Chalmers
Journal:  BMC Cell Biol       Date:  2014-02-14       Impact factor: 4.241

4.  Investigation of a commercial ELISA for the detection of canine procalcitonin.

Authors:  A N K Floras; M K Holowaychuk; D C Hodgins; H S Marr; A Birkenheuer; S Sharif; A M E Bersenas; D Bienzle
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

5.  A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.

Authors:  Oscar B Torres; Joshua F G Antoline; Fuying Li; Rashmi Jalah; Arthur E Jacobson; Kenner C Rice; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2015-12-16       Impact factor: 4.142

6.  Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation.

Authors:  Baichun Xing; Linlin Yang; Yanan Cui
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.